CELLARTIS
Cellartis AB is a Swedish/British biotechnology company focused on pluripotent stem cells and technology for drug discovery research, toxicity testing and regenerative medicine Since 2001, Cellartis has worked globally with industry and academia, platform providers and end users to develop the next generation of advanced stem cell products and technologies. The company leverages a deep experience in stem cell handling, scale up and differentiation into mature and functional human cells. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools today.
CELLARTIS
Industry:
Biotechnology
Founded:
2001-01-01
Address:
Göteborg, Vastra Gotaland, Sweden
Country:
Sweden
Website Url:
http://www.cellectis-stemcells.com
Total Employee:
51+
Status:
Active
Contact:
46 31 758 09 00
Email Addresses:
[email protected]
Total Funding:
8 M EUR
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Genedata AG
Genedata develops sophisticated computational solutions for drug discovery and related research processes in the life sciences.
Investors List
BioFund Management
BioFund Management investment in Venture Round - Cellartis
T-bolaget
T-bolaget investment in Venture Round - Cellartis
Catella Healthcare Investments
Catella Healthcare Investments investment in Venture Round - Cellartis
Innovations Kapital
Innovations Kapital investment in Venture Round - Cellartis
Official Site Inspections
http://www.cellectis-stemcells.com
Unable to get host informations!!!
